How New Ketamine Drug Helps with Depression

From YaleMedicine.org
Yale Medicine is a leader in research demonstrating how ketamine is an effective treatment for depression
Yale Medicine is a leader in research demonstrating how ketamine is an effective treatment for depression

On March 5, 2019 the Food and Drug Administration (FDA) approved the first truly new medication for major depression in decades. The drug is a nasal spray called esketamine, derived from ketamine—an anesthetic that has made waves for its surprising antidepressant effect.  

Interestingly, studies from Yale research labs showed that the drug ketamine, which was widely used as anesthesia during surgeries, triggers glutamate production, which, in a complex, cascading series of events, prompts the brain to form new neural connections. This makes the brain more adaptable and able to create new pathways, and gives patients the opportunity to develop more positive thoughts and behaviors. This was an effect that had not been seen before, even with traditional antidepressants.  

Ketamine is a highly effective treatment for depression. Now there is a new FDA drug approved to also help treat depression called Spravato. Call (424) 332-5550 to learn more.

Read the full article at YaleMedicine.org here.

Related Posts

Help Is Available


(424) 359-1488

FREE CONSULTATION

Start Your New Journey in Life

Visit us in our comfortable Beverly Hills location.